Potassium and Yervoy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Yervoy (ipilimumab). Common drug interactions include death among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Yervoy. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.



On Aug, 07, 2026

62 people who take Potassium and Yervoy together, and have interactions are studied.

Potassium and Yervoy drug interactions.

What are the common drug interactions of Potassium and Yervoy, by gender? *:

female:

  1. Death
  2. Malignant neoplasm progression (cancer tumour came back)
  3. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  4. Arthralgia (joint pain)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Hepatitis (inflammation of the liver)
  7. Hepatitis acute
  8. Hyperglycaemia (high blood sugar)
  9. Neck mass (mass in neck)
  10. Neuropathy peripheral (surface nerve damage)

male:

  1. Urinary tract infection
  2. Death
  3. Fatigue (feeling of tiredness)
  4. Pneumonia
  5. Headache (pain in head)
  6. Altered state of consciousness (altered state of mind)
  7. Cholecystitis acute (rapid infection of gallbladder)
  8. Conjunctivitis (pink eye)
  9. Delirium (wild excitement)
  10. Device related infection

What are the common drug interactions of Potassium and Yervoy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal distension
  2. Fatigue (feeling of tiredness)
  3. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Hepatitis acute
  3. Thyrotoxic crisis (a life threatening condition due to excess secretion of thyroid hormone)
  4. Toxic skin eruption (skin breakdown due to toxic substance)
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

40-49:

  1. Constipation
  2. Diarrhoea
  3. Flatulence (flatus expelled through the anus)
  4. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Neuropathy peripheral (surface nerve damage)

50-59:

  1. Altered state of consciousness (altered state of mind)
  2. Death
  3. Device related infection
  4. Encephalitis (inflammation of the brain)
  5. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  6. Platelet count decreased
  7. Speech disorder
  8. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  9. Tumour haemorrhage (bleeding from tumour)
  10. Herpes zoster

60+:

  1. Death
  2. Urinary tract infection
  3. Pneumonia
  4. Headache (pain in head)
  5. Cholecystitis acute (rapid infection of gallbladder)
  6. Conjunctivitis (pink eye)
  7. Delirium (wild excitement)
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Febrile infection (infection with temperature rise)
  10. Hypernatraemia (an abnormally high plasma concentration of sodium ions)

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 16 people, 25.81%
  2. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 12 people, 19.35%
  3. Lung Cancer - Non-Small Cell (lung cancer): 10 people, 16.13%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Yervoy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Yervoy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yervoy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yervoy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and ipilimumab (the active ingredients of Potassium and Yervoy, respectively), and Potassium and Yervoy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: